scholarly journals New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress

2010 ◽  
Vol 285 (45) ◽  
pp. 34355-34363 ◽  
Author(s):  
María I. Ayuso ◽  
Macarena Hernández-Jiménez ◽  
María E. Martín ◽  
Matilde Salinas ◽  
Alberto Alcázar
2013 ◽  
Vol 33 (8) ◽  
pp. 1173-1181 ◽  
Author(s):  
María Irene Ayuso ◽  
Emma Martínez-Alonso ◽  
Cristina Cid ◽  
Maria Alonso de Leciñana ◽  
Alberto Alcázar

Transient brain ischemia induces an inhibition of translational rates and causes delayed neuronal death in selective regions and cognitive deficits, whereas these effects do not occur in resistant areas. The translational repressor eukaryotic initiation factor (elF) 4E-binding protein-2 (4E-BP2) specifically binds to eIF4E and is critical in the control of protein synthesis. To link neuronal death to translation inhibition, we study the eIF4E association with 4E-BP2 under ischemia reperfusion in a rat model of transient forebrain ischemia. Upon reperfusion, a selective neuronal apoptosis in the hippocampal cornu ammonis 1 (CA1) region was induced, while it did not occur in the cerebral cortex. Confocal microscopy analysis showed a decrease in 4E-BP2/eIF4E colocalization in resistant cortical neurons after reperfusion. In contrast, in vulnerable CA1 neurons, 4E-BP2 remains associated to eIF4E with a higher degree of 4E-BP2/eIF4E colocalization and translation inhibition. Furthermore, the binding of a 4E-BP2 peptide to eIF4E induced neuronal apoptosis in the CA1 region. Finally, pharmacological-induced protection of CA1 neurons inhibited neuronal apoptosis, decreased 4E-BP2/eIF4E association, and recovered translation. These findings documented specific changes in 4E-BP2/eIF4E association during ischemic reperfusion, linking the translation inhibition to selective neuronal death, and identifying 4E-BP2 as a novel target for protection of vulnerable neurons in ischemic injury.


2018 ◽  
Vol 24 (5) ◽  
pp. 645-654 ◽  
Author(s):  
Seidai Wada ◽  
Etsuro Hatano ◽  
Tomoaki Yoh ◽  
Naohiko Nakamura ◽  
Yukihiro Okuda ◽  
...  

1989 ◽  
Vol 9 (11) ◽  
pp. 5055-5061
Author(s):  
D J Haile ◽  
M W Hentze ◽  
T A Rouault ◽  
J B Harford ◽  
R D Klausner

The 5' untranslated region of the ferritin heavy-chain mRNA contains a stem-loop structure called an iron-responsive element (IRE), that is solely responsible for the iron-mediated control of ferritin translation. A 90-kilodalton protein, called the IRE binding protein (IRE-BP), binds to the IRE and acts as a translational repressor. IREs also explain the iron-dependent control of the degradation of the mRNA encoding the transferrin receptor. Scatchard analysis reveals that the IRE-BP exists in two states, each of which is able to specifically interact with the IRE. The higher-affinity state has a Kd of 10 to 30 pM, and the lower affinity state has a Kd of 2 to 5 nM. The reversible oxidation or reduction of a sulfhydryl is critical to this switching, and the reduced form is of the higher affinity while the oxidized form is of lower affinity. The in vivo rate of ferritin synthesis is correlated with the abundance of the high-affinity form of the IRE-BP. In lysates of cells treated with iron chelators, which decrease ferritin biosynthesis, a four- to fivefold increase in the binding activity is seen and this increase is entirely caused by an increase in high-affinity binding sites. In desferrioxamine-treated cells, the high-affinity form makes up about 50% of the total IRE-BP, whereas in hemin-treated cells, the high-affinity form makes up less than 1%. The total amount of IRE-BP in the cytosol of cells is the same regardless of the prior iron treatment of the cell. Furthermore, a mutated IRE is not able to interact with the IRE-BP in a high-affinity form but only at a single lower affinity Kd of 0.7 nM. Its interaction with the IRE-BP is insensitive to the sulfhydryl status of the protein.


2015 ◽  
Vol 87 (1) ◽  
pp. 85-94 ◽  
Author(s):  
Mark C. Dessing ◽  
Alessandra Tammaro ◽  
Wilco P. Pulskens ◽  
Gwendoline J. Teske ◽  
Loes M. Butter ◽  
...  

Cells ◽  
2019 ◽  
Vol 8 (11) ◽  
pp. 1370 ◽  
Author(s):  
Kim ◽  
Cho ◽  
Jung ◽  
Yoo ◽  
Oh ◽  
...  

In a previous study, we utilized a proteomic approach and found a significant reduction in phosphatidylethanolamine-binding protein 1 (PEBP1) protein level in the spinal cord at 3 h after ischemia. In the present study, we investigated the role of PEBP1 against oxidative stress in NSC34 cells in vitro, and ischemic damage in the rabbit spinal cord in vivo. We generated a PEP-1-PEBP1 fusion protein to facilitate the penetration of blood-brain barrier and intracellular delivery of PEBP1 protein. Treatment with PEP-1-PEBP1 significantly decreased cell death and the induction of oxidative stress in NSC34 cells. Furthermore, administering PEP-1-PEBP1 did not show any significant side effects immediately before and after ischemia/reperfusion. Administration of PEP-PEBP1 improved the Tarlov’s neurological score at 24 and 72 h after ischemia, and significantly improved neuronal survival at 72 h after ischemia based on neuronal nuclei (NeuN) immunohistochemistry, Flouro-Jade B staining, and western blot study for cleaved caspase 3. PEP-1-PEBP1 administration decreased oxidative stress based on malondialdehyde level, advanced oxidation protein products, and 8-iso-prostaglandin F2α in the spinal cord. In addition, inflammation based on myeloperoxidase level, tumor necrosis factor-α level, and high mobility group box 1 level was decreased by PEP-1-PEBP1 treatment at 72 h after ischemia. Thus, PEP-1-PEBP1 treatment, which decreases oxidative stress, inflammatory cytokines, and neuronal death, may be an effective therapeutic strategy for spinal cord ischemia.


Shock ◽  
2015 ◽  
Vol 43 (1) ◽  
pp. 24-30 ◽  
Author(s):  
Andrew Godwin ◽  
Weng-Lang Yang ◽  
Archna Sharma ◽  
Adam Khader ◽  
Zhimin Wang ◽  
...  

2015 ◽  
Vol 28 (12) ◽  
pp. 1436-1444 ◽  
Author(s):  
Haifeng Gu ◽  
Minghua Xie ◽  
Liqian Xu ◽  
Xiaojun Zheng ◽  
Yunmei Yang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document